Hepatocellular carcinoma: treatment with transcatheter arterial chemoembolization

• Published in: European journal of radiology Vol. 32; no. 1; pp. 86 - 89
• Main Authors: Acunaş, B, Rozanes, I
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier Ireland Ltd 01.10.1999
• Subjects: Antineoplastic Combined Chemotherapy Protocols - administration & dosage; Blood vessels; Carcinoma, Hepatocellular - therapy; Chemoembolization; Chemoembolization, Therapeutic; Diseases; Doxorubicin - administration & dosage; Drug infusion; Drug products; Ethanol - administration & dosage; Female; Humans; Laser Coagulation; Liver neoplasms; Liver Neoplasms - therapy; Male; Mitomycin - administration & dosage; Noninvasive medical procedures; Oncology; Therapy; Therapy; Liver neoplasms; Chemoembolization
• ISSN: 0720-048X; 1872-7727
• DOI: 10.1016/S0720-048X(99)00117-5

This article presents a review of the literature regarding the use of transcatheter arterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). There have been two different approaches to the treatment: (a) percutaneous tumor ablation methods which can be divided into injectable and thermal methods; percutaneous ethanol injection (PEI) is the most widely used method, and (b) TACE. PEI is the treatment of choice for single HCCs smaller or equal to 3 cm in size. For patients with large HCCs combined TACE and PEI is probably the most effective nonsurgical treatment. In the presence of multiple HCC nodules, TACE remains the treatment of choice.